RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Applied BioCode Stock

Applied BioCode Dividend 2024

Applied BioCode Dividend

0 TWD

Applied BioCode Dividend yield

Ticker

6598.TW

ISIN

KYG0488D1051

How much dividend does Applied BioCode 2024 pay?

According to the latest status from September 2024, Applied BioCode paid a total of 0 TWD per share in dividends within the last 12 months. With the current Applied BioCode price of 22.25 TWD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Applied BioCode Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Applied BioCode Dividend Safe?

Applied BioCode has been increasing the dividend for 0 years.

Over the past 9 years, Applied BioCode has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Applied BioCode's Dividend Distributions

Applied BioCode’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Applied BioCode's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Applied BioCode's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Applied BioCode’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Applied BioCode Aktienanalyse

What does Applied BioCode do?

Applied BioCode Corp is a California-based company that focuses on the development and marketing of diagnostic instruments and tests. The company was founded in 2004 by an experienced management team and has since developed a number of groundbreaking technologies to improve the diagnosis of diseases such as cancer, infectious diseases, and autoimmune diseases. The business model of Applied BioCode Corp is based on the development of innovative diagnostic instruments and test systems based on proprietary technologies. The company has a strong partnership with a leading manufacturer of diagnostic automation systems, allowing a wide range of tests for various diseases to be offered. Applied BioCode Corp also works closely with leading research and development organizations to leverage the latest insights in the field of diagnostics. One of the divisions of Applied BioCode is molecular diagnostics, which is an essential component of modern medicine. Molecular diagnostics enables the detection of genetic changes and deviations related to diseases. Applied BioCode's technology allows for rapid and precise identification of pathogens in clinical samples such as blood, urine, and tissue samples. Another important area for Applied BioCode is infectious disease diagnostics. The company has developed a range of test systems based on a variety of infectious diseases such as influenza, tuberculosis, and sexually transmitted diseases such as chlamydia and gonorrhea. These tests can be performed individually or as a group to facilitate disease diagnosis and improve treatment. Applied BioCode also offers tests for the detection of oncological markers. These tests are crucial for the early detection of cancer and monitoring the treatment of cancer patients. Applied BioCode's technology enables rapid and precise identification of cancer cells in blood or tissue, which can improve the effectiveness of treatment. Another important product of Applied BioCode is the BioCode Analyzer, an automated diagnostic instrument. The BioCode Analyzer is a high-throughput system capable of performing multiple tests simultaneously. The analyzer is equipped with a disposable chip that allows for quick and easy diagnosis. This makes the BioCode Analyzer a powerful tool for laboratory automation, providing fast and accurate diagnosis for a variety of diseases. Applied BioCode is also dedicated to researching and developing new technologies. The company has an active pipeline of new products and technologies to further improve diagnostic accuracy and the number of feasible tests. Applied BioCode is also developing new applications for its technologies to improve the diagnosis and treatment of diseases in various ways. In summary, Applied BioCode Corp plays an important role in the field of diagnostic technology. The company has developed a wide range of innovative diagnostic tests and instruments that enable diseases to be quickly and accurately detected. With its strong partnership with leading diagnostic automation system manufacturers and research organizations, Applied BioCode will continue to stay at the forefront and improve diagnostic practice. Applied BioCode is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Applied BioCode stock

How much dividend does Applied BioCode pay?

Over the past 12 months, Applied BioCode paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Applied BioCode is expected to pay a dividend of 0 TWD.

What is the dividend yield of Applied BioCode?

The current dividend yield of Applied BioCode is .

When does Applied BioCode pay dividends?

Applied BioCode pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Applied BioCode?

Applied BioCode paid dividends every year for the past 0 years.

What is the dividend of Applied BioCode?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Applied BioCode located?

Applied BioCode is assigned to the 'Health' sector.

Wann musste ich die Aktien von Applied BioCode kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Applied BioCode from 9/27/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Applied BioCode pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of Applied BioCode in the year 2023?

In the year 2023, Applied BioCode distributed 0 TWD as dividends.

In which currency does Applied BioCode pay out the dividend?

The dividends of Applied BioCode are distributed in TWD.

Andere Kennzahlen von Applied BioCode

Our stock analysis for Applied BioCode Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Applied BioCode Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.